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Background: Staphylococcus aureus enterotoxin C2
(SEC2) belongs to a family' of proteins, termed 'super-
antigens', that form complexes with class II MHC mol-
ecules enabling them to activate a substantial number of
T cells. Although superantigens seem to act by a common
mechanism, they vary in many of their specific inter-
actions and biological properties. Comparison of the
structure of SEC2 with those of two other superantigens
- staphylococcal enterotoxin B (SEB) and toxic shock
syndrome toxin-1 (TSST-1) - may provide insight into
their mode of action.
Results: The crystal structure of SEC2 has been deter-
mined at 2.0 A resolution. The overall topology of the
molecule resembles that of SEB and TSST-1, and the
regions corresponding to the MHC class II and T-cell
receptor binding sites on SEB are quite similar in SEC2.
A unique feature of SEC2 is the presence of a zinc ion
located in a solvent-exposed region at the interface
between the two domains of the molecule. The zinc ion
is coordinated to Asp83, Hisl 18, Hisl22 and Asp9* (from
the neighbouring molecule in the crystal lattice). Atomic
absorption spectrometry demonstrates that zinc is also
bound to SEC2 in solution.
Conclusions: SEC2 appears to be capable of binding to
MHC class II molecules in much the same manner as
SEB. However, structure-function studies have suggested
an alternative binding mode that involves a different site
on the toxin. The zinc ion of SEC2 lies within this region
and thus may be important for complex formation, for
example by acting as a bridge between the two molecules.
Other possible roles for the metal cation, including a
catalytic one, are also considered.
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Introduction
Staphylococcus aureus and Streptococcus pyogenes produce a
group of related pyrogenic toxins [1] including the
staphylococcal enterotoxins (SEs) A, B, C1, C2, C3, D,
and E [2,3], toxic shock syndrome toxin-1 (TSST-1 [4]),
exotoxins A and B [5], and the streptococcal exotoxins
A, B and C [6]. These toxins cause a number of illnesses,
including toxic shock syndrome and scarlet fever [7]. The
SEs, in particular, are known to be involved in causing
the emesis and diarrhoea associated with staphylococcal
food poisoning [8].
The pyrogenic toxins have been shown to function as
'superantigens' [9]. Like classical antigens, they bind to
MHC class II molecules [10-12] and subsequently form
ternary complexes with receptors on T cells, thereby
stimulating proliferation and increased cytokine produc-
tion by these cells [7,9,13]. However, superantigens differ
from conventional antigens in that they are not subject to
proteolytic processing prior to MHC class II binding and
they interact primarily with regions outside the antigen-
binding groove. Moreover, superantigen-mediated T-cell
activation is achieved predominantly through interaction
with the 13-variable region (Vp) of the T-cell receptor
(TcR) [14,15], whereas ordinary peptide antigens bind to
several variable elements of the TcR. As a consequence,
superantigens stimulate a much larger number of T cells
than do other antigens. Despite the common mechanism
shared by all superantigens, individual members of this
family differ in their interactions with MHC class II
molecules and TcRs and in some of their physiological
effects. X-ray crystallographic studies on SEB [16],
TSST-1 [17,18], and their complexes with an MHC
class II molecule (HLA-DR1) [19,20] have recently
begun to shed light on the structural basis for these
functional differences.
Most of the available data on bacterial superantigens have
been obtained with SEA, SEB and TSST-1. SED and
SEE are only produced in small quantities, thus making
structural studies difficult. However, SECs have been
purified to homogeneity and have been crystallized
[21,22]. The three SEC subtypes differ in amino acid
sequence at only 10 residues [23], but nonetheless
exhibit differences in their interactions with T cells [9].
In order to further understand the molecular basis of the
superantigenic behaviour of SEs, we have determined
the structure of SEC2 at 2.0 A resolution using X-ray
crystallography. The core topology of the molecule is
similar to that reported for SEB [16] and TSST-1
[17,18], with which it shares 63% and -24% sequence
identity, respectively. However, SEC2 contains a novel
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solvent-accessible, hydrophobic 3-barrel (comprising
13-strands [31-[35) together with three a-helices (a3, oa4
and oa6), and has significant similarity to the known
oligosaccharide/oligonucleotide-binding fold ('OB-fold')
structure [24]. Domain 2, which resembles the '-grasp
motif' [25], contains a long helix (a5), which interacts
with helix a6 of domain 1 on one side, and is sur-
rounded by a highly twisted -sheet structure (6-312)
on the other. This domain also contains the N-terminal
segments (two short helices, oal and ac2) of the molecule.
Fig. 1. The polypeptide fold for SEC2. Helices are coloured in red
(the 310-helix being drawn more thinly than the a-helices),
-strands in green and loops in yellow. The N and C termini are
labelled. The large blue sphere represents the zinc ion. The disul-
phide bridge is shown in ball-and-stick representation. (Figure
drawn with MOLSCRIPT [76] and Raster 3D [77].)
zinc-binding site which may be involved in MHC class
II molecule interactions, thereby mediating the super-
antigenic properties of the toxin.
Results and discussion
Molecular structure
The two domains of SEC2 are packed together to
form a compact molecule of approximate dimensions
45 A x 53 A x 43 A (Fig. 1). Domain 1 contains a
The overall structure of SEC2 (Figs 1,2a) resembles that
of SEB and TSST-1 (Fig. 2b). Sequence alignments for
the three toxins, along with the details of their secondary
structural elements, are shown in Figure 3. The regions
of the SEC2 structure that deviate most significantly
from SEB involve residues 51-61 (2-33 loop), 97-110
(the disulphide loop and part of 135), 120-129 (the
31 0-turn and part of 36), 137-140 (6 and 37), 152-155(P138) and 193-194 (10). The smaller protein, TSST-1
(194 amino acids), which is only distantly related to SEB
and SEC2 (both with 239 amino acids), lacks the N-ter-
minal helices o1l, or2 and ot4 of SEC2 and is severely
truncated in several loop regions.
The zinc-binding site
When the protein was crystallized [22] no divalent metal
ions were added to the crystallization medium. However,
a strong persistent feature of density (above 9u), which
could not be accounted for by a water molecule, was
always present in the calculated difference Fourier maps
during the refinement of the SEC2 structure. This fea-
ture was assigned as a zinc ion on the basis of several lines
of evidence. Inclusion of the zinc atom in the refinement
results in an improvement of both Rfree and Rcryst by 1%
Fig. 2. Stereoviews displaying (a) a Ca
trace for SEC2 and (b) a comparison of
Ca traces for SEC2 (black), SEB (red)
and TSST-1 (green). The rms deviation
between the Ca positions of 206 equiv-
alent residues in SEC2 and SEB crystal
structures is 0.94 A and the corre-
sponding deviation between the Ca
positions of 181 equivalent residues in
SEC2 and TSST-1 crystal structures is
2.95 A. Structural alignments were per-
formed using the Structure Homology
Program (SHP) [64].
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Fig. 3. Structure-based alignment of the amino acid sequences of SEC2, SEB and TSST-1 as determined using the program SHP 164].
Every tenth residue of each sequence is numbered. In SEC2, the solvent-inaccessible residues (<20 A2 of exposed surface as calculated
using the program DSSP [78]) are indicated by stars (*) and residues involved in crystal-packing contacts (as given by the program
X-PLOR [67]) are indicated by the hash (#) symbol. Secondary-structure elements as determined by DSSP are also shown. The residues
in SEB [16,19] and TSST-1 [18,20] involved in MHC class II and TcR binding are highlighted in red and green, respectively. (SEB
residues Tyr89 and Gln92 have been implicated in both interactions.) SEC2 residues corresponding to those in SEB which are involved
in MHC and TcR interactions are indicated by the same colours. In addition, two SEC2 peptides proposed to bind MHC molecules [46]
are highlighted in yellow. The zinc ligands in SEC2 are shown highlighted in blue. (Figure drawn with ALSCRIPT [79].)
(Rfree from 27.5% to 26.4% and Rcryst from 22.8% to
21.8%). The putative zinc ion (Fig. 4a) is in close prox-
imity to two imidazole groups (from His 18 and His122)
and two carboxylate groups (from Asp83 and Asp9* [on a
symmetry-related molecule]). Such groups are amongst
those that commonly serve as ligands in binding sites for
this metal [26]. The spacing between His118 and His122
in the primary structure is also typical of Zn2 + sites,
which in general include two ligands that are separated
by one to three amino acids. The metal-ligand distances
(1.93-2.23 A) and coordination angles (93.6-123.8 °) are
within the range seen for tetrahedrally coordinated zinc
ions in proteins whose three-dimensional structures have
been determined previously (for examples, see [27-29]).
The low temperature factors for the zinc ion and its lig-
ands (9.5-13.9 A2 ) in SEC2 are also consistent with those
expected for a tightly bound metal ion.
Direct physical evidence that zinc is a constituent of
SEC2 was obtained by atomic absorption spectrometry,
which revealed the presence of 0.53 mole of zinc bound
per mole of protein in the preparation used to grow
crystals for X-ray diffraction (see the Materials and
methods section). Because the occupancy of the zinc
atom observed in the crystal structure was nearly 1.0, it
may be that the zinc-SEC2 complex crystallizes more
readily than the apoprotein. Indeed, this is reasonable in
light of the position of the zinc ion as a bridge between
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Fig. 4. The zinc-binding site of SEC2.
(a)Amino acid residues that interact
with zinc are shown. The zinc ion is rep-
resented by a large blue sphere. Two
protein molecules contribute atoms to
this site. The ligands Asp83, Hisll 18 and
His122 are from one molecule and
Asp9* is from the other. (Figure drawn
using O [70].) (b) Stereo diagram show-
ing the superposition of all non-hydro-
gen atoms for residues His-Glu-X-X-His
in SEC2 (black), thermolysin (red) and
the catalytic domain of fibroblast col-
lagenase (green), performed using the
'Analyze Structure Homology' (ASH)
program [64]. The rms deviations for
Cacs are: SEC2 versus thermolysin,
1.05 A; SEC2 versus collagenase,
1.12 A, and thermolysin versus collage-
nase, 0.20 A. (Figure drawn using
MOLSCRIPT [76].)
neighbouring molecules in the crystal. Consistent with
this view, a preparation of SEC2 which had failed to
crystallize was found to contain only a trace quantity of
zinc (less than 0.06 mole per mole of protein). A possi-
ble explanation for the variable, substoichiometric quan-
tities of zinc measured in the SEC2 preparations is that
part of the purification procedure [22] was performed at
a pH (pH 5) at which appreciable dissociation of the
metal ion may occur.
The apoSEC2 preparation was used to further examine
the zinc-binding properties of the toxin. Three molar
equivalents of zinc nitrate were added to the protein and
the amount bound was determined by analyzing the
final retentate and filtrate obtained after ultrafiltration-
dialysis. The retentate contained 57.5 ptM zinc (repre-
senting bound plus free metal) together with 53.2 plM
SEC2; the zinc concentration in the filtrate (representing
free metal) was 1.8 p.M. Thus, 1.05 mole of zinc was
incorporated per mole of toxin. These data indicate that
the dissociation constant for the zinc-SEC2 complex is
well below 1 uM and, therefore, that a zinc atom is an
intrinsic component of SEC2 in solution under normal
physiological conditions.
The zinc-binding site observed in the SEC2 crystal
structure (Figs 1,4a) is located on the surface of the pro-
tein at the interface between two SEC2 molecules. It is
formed by residues from three elements of secondary
structure: the 3-sheet of domain 1 (Asp83 [on strand 34]
and Hisll18 [on strand 35]); the 13-turn that connects
strand 35 with the 31 0-helix of domain 2 (Hisl22), and
the or1 helix of domain 2 of the symmetry-related mol-
ecule (Asp9*). An analogous recruitment of zinc-binding
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ligands from neighbouring molecules in a protein crystal
was reported for the serine protease tonin [30], although
in that case the protein, unlike SEC2, was crystallized
from a buffer that contained a high concentration of zinc
ions and the metal is not thought to be part of the native
structure in solution.
The intermolecular contacts of SEC2 in the crystalline
state are presumably absent when the protein is in solu-
tion. Thus the zinc ion, although tightly bound, may be
coordinated only to the three ligands, Asp83, Hisl 18, and
His122, that derive from a single molecule. Coordination
of a zinc ion by three protein ligands (plus a water mol-
ecule) is, in general, indicative of a catalytic role for the
metal [31]. SEC2, however, has no known enzymatic
activity and a catalytic role for the zinc ion seems
unlikely. The zinc-binding site of SEC2 is not conserved
in SEA, SEB, SED or SEE. Although Asp83 and Hisll8
are conserved in all SEs, His122 is replaced by arginine
(in SEA and SEE), glutamine (in SEB) and lysine (in
SED) and these residues are relatively poor ligands for
zinc ions. Mutagenesis results on other zinc-containing
enzymes (e.g. leukotriene A4 hydrolase [32]) suggest that
the residues corresponding to Asp83 and Hisll18 in the
other SEs would not, by themselves, be sufficient to
coordinate the metal effectively. Thus, a catalytic role for
the zinc ion in SEC2 might imply that the mechanism of
action of this toxin differs in some fundamental respect
from that of the others. This seems improbable in view of
the apparent similarity of the superantigenic, pyrogenic
and emetic properties of these toxins.
Despite this consideration, the possibility that SEC2 is a
zinc-dependent enzyme cannot be excluded. Indeed, the
presence of the zinc ion in SEC2 may point to a hitherto
unsuspected aspect of the protein's function. In this
regard, we have investigated the potential signiificance of
the His-Glu-Gly-Asn-His sequence that forms part of
the metal-binding site in SEC2. His-Glu-X-X-His is a
common zinc-bindirig motif in zinc proteases, and sev-
eral proteins - including leukotriene A4 hydrolase [33],
tetanus toxin [34], botulinum neurotoxin [35,36], and
the enterotoxin of Bacteroidesfiragilis [37] - were discov-
ered to possess peptidase activity only after they were rec-
ognized to contain this sequence. However, the
conformation of these residues in SEC2 differs markedly
from those observed thus far in crystal structures of these
proteases. The zinc-coordinating pentapeptides in ther-
molysin (Protein Data Bank [PDB] code 7TLN [29]) and
collagenase (PDB code 1CGL [38]) are compared with
the corresponding residues in SEC2 in Fig. 4b. A poten-
tially significant observation is that the glutamate side
chain in SEC2 has a different orientation from that of the
glutamate in the proteases, where it is thought to partici-
pate in catalysis by removing a proton from the water
molecule that provides the fourth zinc ligand. In fact,
examination of the SEC2 crystal structure reveals that no
residue is situated appropriately to act on the zinc-
bound water molecule that would replace the Asp9*
carboxylate when the toxin is in solution. Although these
observations suggest that SEC2 does not have proteolytic
or other hydrolytic activity, this question must remain
open in the absence of direct functional information.
The major non-catalytic role for zinc ions in proteins is
'structural', that is, helping to stabilize a local conforma-
tion required for interactions with DNA and other mol-
ecules [26]. As all structural zinc-binding sites defined by
crystallography or NMR comprise four protein ligands
and no bound water molecules, a role of this type for the
metal in SEC2 again appears to be somewhat improbable.
Zinc ions have also been proposed to be capable of acting
as bridges that participate directly in protein-protein
interactions, although this has not yet been confirmed by
structural determinations. Binding of human growth
hormone (hGH) to the human prolactin receptor is
strongly dependent on zinc and the results of mutagenesis
studies indicate that the zinc-binding site comprises three
residues from hGH and one from the receptor [39]. In
contrast with SEC2, hGH by itself does not bind zinc to
any measurable extent - the additional presence of the
receptor is required. Zinc has also been shown to be
important for the binding of SEA and SEE to MHC class
II molecules and, on the basis of indirect evidence, three
of the ligands are again thought to be provided by one of
the proteins, namely SEA or SEE, and the fourth by the
MHC molecule [40,41]. It is possible that the zinc ion in
SEC2 plays an analogous role (although its binding site is
distinct from that in SEA or SEE) and contributes to the
interaction of the toxin with MHC (see below) or some
other molecule that supplies an additional ligand.
Finally, we note that Asp83, Hisll 18 and His122 of SEC2
are conserved in the related S. pyogenes exotoxin A, as are
the residues between the two histidines (Glu-Gly-Asn)
and a large proportion of the neighbouring residues [42].
Thus, it is likely that this toxin, which is involved in
scarlet fever, also contains zinc and that it shares with
SEC2 whatever functional property is dependent on the
metal ion.
The MHC class II binding site
Detailed pictures of the interactions of SEB and TSST-1
with HLA-DR1 molecules have recently been obtained
by X-ray crystallography [19,20]. These studies reveal
both similarities and differences in the binding modes of
the two toxins. Thirteen of the contact residues on SEB
and TSST-1 (out of 19 and 24, respectively) are struc-
turally equivalent, and 11 of the DR1 residues involved
are the same (Fig. 3). In the SEB-DR1 complex, the
major interactions link the 3-barrel of domain 1 of the
toxin to the a-chain oal helix of DR1, close to the edge
of the peptide-binding groove. Although the P-barrel of
TSST-1 also makes important contacts with DR1 al, this
toxin is positioned differently. Consequently, it covers
almost half of the peptide-binding site and interacts with
helices from both the axl and 31 domains of DRI and
with the bound peptide. Despite the apparent overlap of
their binding sites on DR1, SEB and TSST-1 do not
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compete with each other for binding to cells that express
DR1 molecules, perhaps reflecting the participation of
cellular factors such as peptides [43].
The high degree of structural similarity and amino acid
sequence identity between SEC2 and SEB suggests that
these toxins might bind in analogous fashion to MHC
class II molecules. In order to examine this question, we
have modelled the SEC2-MHC molecule complex by
docking the SEC2 structure onto DR1 in the SEB-DR1
complex [19] in the same orientation as SEB. As the
SEB-DR1 structure has not yet been refined at high res-
olution, we shall confine our discussion to the most
salient features. The modelled SEC2-DR1 complex
shows a reasonable fit of the two molecules without any
obvious stereochemical impediments. The interface con-
sists of residues from the 31-32 loop, 33 strand, ot4
helix, [34-35 loop, 35 strand and a6 helix of SEC2 (Figs
3,5) and the oal domain of DR1. Twelve of the SEC2
residues are identical to those in SEB that make contact
with DR1, and these superimpose well with their SEB
counterparts, participating in a similar set of molecular
interactions at the interface. In particular, the major
hydrogen-bonding interactions of SEB with Tyrl3,
Gln18, Lys39 and Lys67 of DR1 oil are all maintained in
the modelled SEC2-DR1 complex. There are seven SEB
residues at the interface that are not conserved in SEC2:
Glu43 is replaced by lysine, Tyr46 by alanine, Phe47 by
histidine, Arg65 by lysine, Lys69 by leucine, Lys71 by
glutamate and Gln92 by asparagine. Of these, Lys43,
Fig. 5. Worm representation of the SEC2 molecule illustrating
potential sites of interaction with MHC class II and TcR mol-
ecules. The orientation of the molecule is similar to that in
Figure 1. Regions implicated in MHC class II binding on the basis
of homology modelling from the SEB-DRI complex structure
[19] are in red and those implicated by peptide data [461 are in
yellow. A minor overlap occurs between these two regions in
helix a4 (residues 78-79) and is indicated in red. Segments
implicated in TcR binding are in green. Residues lying within
both the SEB-like MHC-binding site and the TcR-binding site are
indicated in purple. The zinc atom is shown in blue.
Ala46, His47 and Leu69 in SEC2 are involved in similar
main-chain hydrogen bonds and/or side-chain van der
Waals contacts with DR1 residues as are found in the
SEB-DR1 complex. However, the van der Waals contact
involving the side chain of residue 65 is absent in SEC2.
The side chain of Glu71 does not appear to interact with
DR1 and our modelling exercise therefore suggests that
it may not be involved in DR1 binding. On the other
hand, Asn92 seems to make a better hydrogen bond with
Gln57 from DR1 than does Gln92 of SEB. As in the
SEB complex,. the DRI peptide is located some distance
(10 A) away from the interface.
The SECs bind to MHC class II molecules of the HLA-
DQ isotype as well as to HLA-DR, but apparently do
not bind HLA-DP molecules to a significant extent
[44,45]. DQ and DP differ from DR at numerous posi-
tions involved in the SEB-DR and modelled SEC2-DR
interfaces (6-9 for DQ and 7 for DP). Jardetzky et al.
[19] have noted that many of the side chains that make
key contacts with SEB are maintained or conservatively
replaced in DQ, and have suggested that the substitution
of Gln18 by proline in DQ is an important reason for the
weaker binding of SEB to DQ relative to its binding to
DR. If SEC2 does indeed bind MHC class II molecules
as in this model, it would seem that any conformational
disruption caused by the proline replacement has no
appreciable influence on the overall interaction with
SEC. DP has several substitutions in the segment con-
taining residue 18 that may diminish binding and, more-
over, has a replacement of Lys67 by asparagine that might
eliminate this major stabilizing interaction [19].
Although an SEB-like mode for binding of SEC2 to
MHC class II molecules seems structurally plausible, the
limited experimental data available in fact suggest that the
region of the SECs involved in the interaction may differ
from that utilized in SEB. These results, which were
obtained with SEC1 mutants and peptides and inter-
preted with reference to the unpublished SEC3 crystal
structure [46], point to the 'a5 groove' between the two
domains as the binding site (Figs 1,5). Peptides represent-
ing residues on either side of the lower portion of this
groove - that is, 74-86 (a4 helix to 4 strand in
domain 1) and 148-162 (end of 37 strand to the middle
of a5 helix in domain 2) - stimulated T-cell prolifera-
tion. Deletion mutants lacking residues in the a3 helix in
the upper portion of the groove retained strong MHC-
binding capacity, suggesting that the lower part may be of
greater importance.
It is striking that the zinc ion identified in our SEC2
crystal structure (and presumably also present in SEC1
and SEC3) lies within this region of the toxin, well away
from the SEB-like site. Thus, if the proposed model for
SEC1 is correct, it would appear that the zinc ion is
ideally situated to contribute to MHC binding. More-
over, it is tempting to speculate that it does this by acting
as a bridge: in other words, that the MHC class II mol-
ecule provides a fourth protein ligand to complement the
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three from the toxin. Crystallographic studies on com-
plexes between SEC2 and MHC molecules and investi-
gations of the functional involvement of zinc in MHC
class II binding will ultimately determine the validity of
this hypothesis and reveal whether both of the potential
MHC-binding modes suggested by the present structural
data are utilized in SEC2.
A similar bridging role for the zinc ion in the interactions
of SEA and SEE with HLA-DR1 was proposed previ-
ously [40] in order to account for the marked zinc-
dependence of DR1 binding, although kinetic evidence
[41] had suggested that the zinc-binding site was con-
fined to the toxin. The residues coordinating zinc in SEA
and SEE have been designated as His187, His225 and
Asp227 near the C-terminal end of the molecule; muta-
tions of these amino acids reduce zinc binding, MHC
class II binding, and T-cell stimulating activity (unpub-
lished data of Fraser and Hudson cited in [40]). The anal-
ogous three residues in SEC2 (Ile189, Lys229 and
Glu231) cannot coordinate zinc and are located on 3-
strands 19 and 112 of domain 2, quite distant from both
of the putative MHC-binding sites as well as the region
corresponding to the observed site on TSST-1. These
observations, together with the results of additional
mutational and cross-competition studies [47,48], raise
the possibility that bacterial superantigens have developed
four or more distinct MHC-binding modes.
The TcR-binding site
The V, region of the TcR is the major site of interaction
with staphylococcal superantigens. Putative TcR-binding
sites in the three-dimensional structures of SEB [16,19]
and TSST-1 [18,20] have been assigned on the basis of
mutational evidence and topological considerations. In
SEB, this site lies between the two domains of the pro-
tein in a shallow cavity formed by residues 22-33 (mostly
ca2 helix), 55-61 (2-P3 loop), 87-92 (4 strand and
,4-15 loop), 112 (5 strand) and 210-214 (oa5 helix).
Replacement of residues 23, 60 and 61 in this region
affect T-cell activation without impairing MHC class II
binding [49]. In contrast, the TSST-1 residues implicated
in TcR binding - Tyr115, Glu132, Hisl35, Ile140,
Hisl41 and Tyr144 [50-53] - are located in domain 2,
on the long helix a2 (4 in SEB; a5 in SEC2) and the
17-18 and ot2-P9 loops.
The SECs have VB specificities similar to that of SEB
[9,54], suggesting that the site of interaction of these tox-
ins with TcRs is analogous to that on SEB (Fig. 5).
Indeed, deletion mutants lacking various residues
between positions 19 and 33 (3 helix, corresponding to
a2 in SEB) are mitogenically inactive but can inhibit
both T-cell activation and MHC class II binding by the
native toxin [46]. Moreover, 15 of the 21 residues lining
the cavity that comprises this site are conserved in the
SEC2 (and SEC1) sequence (Fig. 3). Comparison of the
SEC2 and SEB [19] crystal structures reveals that these
residues are positioned similarly in the two toxins. The
six amino acid replacements (Glu22-+Gly, Val26-*Tyr,
Asn31l-His, Ala87-Ser, Tyr91-Val and Gln92-+Asn)
may then account for some or all of the observed differ-
ences in TcR interactions. The substantially greater
divergence in V specificity between SEC2 (and SEB)
relative to TSST-1 [9,54] is not surprising: TSST-1 has
no site that is structurally equivalent to the putative
TcR-binding cavity of SEC2 and SEB [18] and the
TcR-binding region of TSST-1 is poorly conserved in
the SEC2 and SEB structures. SEA and SEE also vary
considerably from SEC2 and SEB in their TcR prefer-
ences [9,55]. Although mutagenesis results suggest that
the same cavity may be involved in TcR recognition
[56], 60% of the corresponding residues in both SEA and
SEE are different.
The disulphide loop
All SEs possess a disulphide loop. The amino acid
sequence and length of this loop vary amongst the SEs;
however, all such residues are conserved among SEC
subtypes. In the crystal structure of SEC2, this loop
(between residues 93-110) is partially disordered and has
diffuse density (this loop is known to be extremely sus-
ceptible to proteolysis [57]) indicative of considerable
flexibility. Residues on the C-terminal side of this loop
have been suggested to be involved in conferring the
emetic property of the SEs [58,59], as they are well con-
served in these toxins, but not in TSST-1, which lacks
this biological activity. Some support for this view is pro-
vided by the lack of emetic activity of mutants of both
SEC1 [59] and SEA [60] in which alanine replaces one
or both of the cysteines. Swaminathan et al. [16] have
proposed that one particular residue in this region
(Hisl21 in SEB and His118 in SECs) may be important
because chemical modification of histidines in SEA [61]
also eliminates emetic activity. However, in the SECs this
histidine participates in an interaction that is absent in the
other SEs: namely, it is a ligand for the zinc ion. This
may imply that the histidine in question is not actually
involved in the emetic activity of these toxins. Alterna-
tively, the histidine may contribute to the emetic activity
of other SEs but not of SEC (i.e. the emetic site may vary
in the different SEs) or the zinc may not be bound to
SEC under the physiological conditions where the criti-
cal interaction responsible for emesis occurs (e.g. if this is
in the stomach, the acidic pH would release the zinc
ion). It appears that emesis involves a complex set of
events and further investigations are required in order to
address these questions.
Biological implications
The bacterial toxins secreted by Staphylococcus
aureus and Streptococcus pyogenes produce a wide
range of clinical conditions including food poi-
scning, toxic shock syndrome and scarlet fever but
their precise mode of action remains unclear.
These molecules are capable of stimulating a large
proportion of T lymphocytes bearing certain VP
elements and are therefore called 'superantigensq
Like normal peptide antigens, superantigens
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require antigen-presenting cells expressing MHC
class II molecules to induce T-cell proliferation.
The T-cell response is known to involve produc-
tion of several cytokines - including inter-
leukins-2, 4 and 6, tumour necrosis factors-a and
3, and interferon-y - which may result in acute
systemic illness and clinical shock.
Crystallographic techniques have allowed consid-
erable progress to be made in understanding the
superantigenic properties of these toxins. To date,
three-dimensional structures for staphylococcal
enterotoxin B and toxic shock syndrome toxin-1
and their complexes with MHC class II molecules
have been determined. These structures have
revealed important differences in the interactions
of the toxins with MHC class II molecules. Results
of mutagenesis and competition studies suggest
that other superantigens may utilize yet additional
binding modes to induce their effects. Interactions
of these toxins with T-cell receptors have yet to be
observed crystallographically, but various models
have been proposed to account for available
functional data.
We have now determined the three-dimensional
structure of staphylococcal enterotoxin C2. This
structure is similar to that of enterotoxin B, most
notably in the regions corresponding to the bind-
ing sites for MHC molecules and T-cell receptors.
A striking and unexpected feature, found only in
the enterotoxin C2 structure to date, is the pres-
ence of a zinc ion which is coordinated to residues
located in a solvent-exposed groove. The metal
ion is bound tightly in solution and is therefore
intrinsic to the protein, suggesting that it may
participate in the biological action of this toxin.
The zinc-binding site contains the characteristic
His-Glu-X-X-His sequence found in many zinc-
containing proteases, but in enterotoxin C2 this
pentapeptide adopts a significantly different con-
formation. The role of the zinc ion in enterotoxin
C2 has yet to be established. Although a catalytic
role cannot be ruled out, the position of the zinc
ion suggests a possible bridging role in binding to
MHC class II molecules.
Materials and methods
Protein crystallization
Details of the purification and crystallization of SEC2 have been
described elsewhere [22,62]. Crystals of purified SEC2 were
grown at 16°C using the hanging drop method with 25-28%
PEG 8000, 0.15 M ammonium sulphate, 0.02% (w/v) sodium
azide, 0.1 M cacodylate buffer (pH 6.5) in the reservoir and
2 mg ml-1 protein in the drop. The crystals belong to space
group P43212 with unit cell dimensions a=b=43.05 A,
c=290.0 A. The crystals diffract to minimum Bragg spacings of
2.0 A at a synchrotron radiation source. There is one molecule
of SEC2 per crystallographic asymmetric unit and approximately
50% of the crystal volume is occupied by solvent.
Diffraction measurements and data processing
Data for the native protein crystals at 2.6 A (AD-lab data set)
were collected at room temperature from two crystals using a
Siemens area detector mounted on a Siemens rotating anode
(CuKoa X-rays, 50 kV, 80 mA). Overall, 1674 frames of data
were collected (0.250 per frame, crystal to detector distance
29 cm, 20 angle 250, 300-360 s per frame exposure). The data
were processed using the XDS package [63]. The two data sets
(Table 1) were scaled using the program 3DSCALE [64].
Two additional data sets, one at medium (3.0 A) resolution
(SRS data set I) and the second one at higher (2.0 A) resolution
(SRS data set II), were collected on station 9.5 of the Synchro-
tron Radiation Source, Daresbury, UK, using a 30 cm diame-
ter MAR-research image plate with X-ray beam (0.2 mm
collimator) of wavelengths 1.009 A and 0.88 A respectively.
One crystal per data set was used with an oscillation range of
0.750 per image for the 3.0 A data set and 0.400 per image for
the 2.0 A data set. The data were indexed, integrated and cor-
rected for Lorentz and polarization effects using the program
DENZO [65]. The details of data processing statistics for the
three data sets used in the structure determination are presented
in Table 1.
Structure determination
The structure of SEC2 was determined by the method of mol-
ecular replacement using the program AMoRe [66] with a
polyalanine search model based on the 2.7 A resolution
SEB-DR1 complex structure [19]. SRS data set I was used dur-
ing molecular replacement. Data in the range 10-4 A were used
in the rotation function searches and in the range 10-4.5 A for
the translation function searches. Using a Patterson cut-offradius
of 25 A, a list of 100 rotation function peaks was obtained, with
the top peak having a correlation coefficient of 14.5 (5.8cr above
the mean). The translation function gave two symmetry-related
solutions with correlation coefficients of 39.0 and 39.7 respec-
tively (4.0a higher than any other peak). During the data collec-
tion there was some ambiguity regarding the space group
assignment for SEC2 crystals. In order to resolve this problem,
translation function search and rigid-body refinement were per-
formed separately for space groups P4 1212 and P43212. The cor-
relation coefficient for the latter space group was significantly
higher, and remained so, after rigid-body minimization using
the program AMoRe (37.7 and 55.9 respectively), indicating
that P43212 was the correct space group.
Table 1. X-ray data collection statistics.
AD-lab set SRS set I SRS set II
Resolution 2.6 A 3.0 A 2.0 A
Wavelength (X) 1.5418 A 1.009 A 0.88 A
N * 36679 39546 119513
Nu? 9011 5672 19015 (1+11 9302)
Overall
completeness 86.9% 92% 95.3% (1+11 97.6)
I/u(l) 23.2 13.6 13.8 (1+11 2.7)
Completeness
of outer shell 87.0% 74.9% 96.7%
Rmerget (%) 7.5 (10.4 from 5.6 (9.3 from 4.4 (8.8 from
2.67-2.58 A) 3.1-3.0 A) 2.07-2.0 A)
(1+11 5.0)
fNumber of measurements. tNumber of unique reflections.
*Rm,,,ge=( I-<l> I1 )/<> where Ij is the observed intensity of
reflection j and <I> is the average intensity of multiple observations.
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Refinement
The output model from AMoRe was subjected to rigid-body
refinement (polyalanine model) with X-PLOR [67] using SRS
data set I from 10-8 A. The stereochemical parameters of Engh
and Huber [68] were used throughout refinement. The crystal-
lographic R-factor, Rct (defined as IIFo I-IF II/ IFo I),
was 46.1% at this stage. AD-Lab data were then used in the
refinement from 8.0-2.6 A. Using the amino acid sequence of
SEC2, a model was built with the program FRODO [69] on
an Evans and Sutherland PS390 graphics system and at later
stages of refinement on a Silicon Graphics Indigo (SGI)2 using
O (version 5.10) [70]. Electron-density maps were calculated
using either X-PLOR [67] or the CCP4 package of programs
[71]. There was no density for the residues 56-60, 96-107,
119-128 and 173-181 in the initial maps. The starting R
value was 48.5% and the Rfree [67] was 47.3% with 5% of the
data omitted. The refinement proceeded smoothly. Three
rounds of positional refinement dropped the Rcryst value to
35.9% and the Rfee to 44.8% with all the temperature factors
set to 20.0 A2. At this stage, sigma-weighted 21 F I -IF c I
maps were calculated using the program SIGMAA [72] and
careful examination of the maps allowed corrections to be
incorporated into the model. Alternating cycles of manual
rebuilding, conventional positional refinement and simulated
annealing, using the slow-cool protocol as implemented in
X-PLOR [67], allowed residues 56-60, 119-128 and 173-181
to be placed in the electron-density map. The behaviour of
Rfree was monitored throughout the refinement procedure.
When the cry't was about 26% and the Rfree 35%, a new
high-resolution data set (SRS data set II) was collected and the
merged data set (SRS data sets I and II) was used as the master
set during the remainder of the refinement. Extension of
refinement from 2.6-2.0 A was performed in 0.1 A resolution
steps. Further refinement, model rebuilding and individual
temperature factor (B-factor) refinement (using all data, 18932
reflections, 8.0-2.0 A) gave a final model with Rc of 20.5%,
a last-recorded Rfree of 25.5% (917 reflections) an rms devia-
tion of bond lengths and bond angles from ideality of 0.009 A
and 1.460, respectively. During the final stages of refinement,
water molecules were inserted into the model only if there
were peaks in the I F I - I F c electron-density maps with
heights greater than 3.0a and they were at hydrogen bond
forming distances from appropriate atoms. 21 Fo I - I Fc I maps
were also used to check the consistency in peaks. Water mol-
ecules with B-factors higher than 50.0 A2 were excluded from
subsequent refinement steps. The average B-factors for protein
atoms, main-chain atoms, water molecules and the zinc ion
are 19.9 A2, 19.5 A2, 21.1 A2 and 11.7 A2, respectively. All
Fig. 6. Representative portion of the
21 Fo-I Fc I electron-density map of
SEC2 contoured at 1.0a using the
refined structure at 2.0 A resolution.
computations were carried out on SGI2 and Vax workstations.
A portion of the SIGMAA-weighted 2 Fo I - I Fc I final elec-
tron-density map is shown in Figure 6.
Validation of the model
The final refined model at 2.0 A comprised 238 residues, 70
water molecules and one zinc ion. The N-terminal glutamate
and the two C-terminal residues (Lys237 and Asn238) have
been modelled as alanines due to poor density in the elec-
tron-density map. Residues 99-103 (part of the disulphide
loop which is exposed to the solvent) have been modelled
using the O database [69] but the side chains have been omit-
ted from the final model due to poor density. The stereo-
chemistry of the model was assessed using X-PLOR [67], O
[70] and PROCHECK [73]. Analysis of the Ramachandran
(4,) plot showed that 89% of the residues lie in the most
favoured regions, and two others (Leu58 and Ala237) are in
generously allowed regions.
Determination of the zinc content of SEC2
Two preparations of lyophilized SEC2 (0.3-0.5 mg) [62] were
each reconstituted in 200 Il of 2 mM HEPES, pH 7.5, and
50 I1 aliquots were analyzed for zinc content by atomic
absorption spectrometry (AAS). One preparation was found to
contain a significant amount of zinc, whereas the other was
virtually devoid of the metal (see the Results and discussion
section). The concentration of free zinc (i.e. not bound to
SEC2) in the first preparation was determined by performing
AAS on an ultrafiltrate obtained by centrifugation of this mat-
erial at 4000 g in a Centricon 10 microconcentrator (Amicon,
Beverly, MA). The ratio of bound versus free zinc was found to
be about 9:1. The zinc-binding capacity of the second SEC2
preparation was investigated by adding 25 nmol of zinc nitrate
to 8.3 nmol of the protein in 500 il of 20 mM HEPES, pH
7.5. This mixture was then washed by performing two cycles
of centrifugation and dilution (each time with 10 volumes of 2
mM HEPES, pH 7.5) in a Centricon 10 device and the zinc
concentrations in the final protein solution and filtrate were
measured by AAS. Centricon membranes were prepared for
use in these experiments by centrifugation with 2 ml of 1 mM
HCI followed by 2 x 1 ml of 2 mM HEPES, pH 7.5. The zinc
concentration in the last filtrate from this washing procedure
was <20 nM in all cases.
Zinc concentrations in protein samples were determined with a
Perkin Elmer 2280 flame atomic absorption instrument
(Norwalk, CT), whereas the substantially lower concentrations
in the filtrates were measured by the more sensitive graphite
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furnace AAS technique using a Perkin Elmer Model 4100 ZL
instrument equipped with an AS-70 autosampler. Absorbance
peak heights (flame) or areas (graphite furnace) were measured
at 213.9 nm. Zinc concentrations were quantitated by compar-
ing samples (diluted in MilliQ water [flame] or 0.2% nitric acid
[graphite furnace]) with standards containing 1.5 jM, 3.1 AM
and 6.1 pM (flame) or 38 nM, 76 nM, 153 nM, 229 nM and
306 nM (graphite furnace) zinc reference solution (Fisher,
Pittsburgh, PA). Protein concentrations were determined by
amino acid analysis using 6-aminoquinolinolyl-N-hydroxy-
succinimidyl carbamate precolumn derivatization [74].
The atomic coordinates of SEC2 will be deposited in the
Brookhaven Protein Data Bank [75].
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